$1.5M SBIR Phase II Awarded for Nanobind Development

Circulomics has been awarded a $1.5M Phase II SBIR grant by the National Institutes of Health (NIH) - National Institute of General Medical Sciences (NIGMS) to create a comprehensive DNA and RNA extraction product portfolio based on the Nanobind technology first developed in Phase I. A press release has been issued with additional details. Circulomics receives coverage on GenomeWeb.

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • LinkedIn Social Icon

701 E Pratt St, Baltimore, MD 21202

INFO@CIRCULOMICS.COM

  • Grey Twitter Icon
  • Grey LinkedIn Icon
  • Grey Facebook Icon